103 related articles for article (PubMed ID: 25673160)
21. Effect of GnT-V knockdown on the proliferation, migration and invasion of the SMMC7721/R human hepatocellular carcinoma drug-resistant cell line.
Li B; Su S; Zhang MY; He L; Wang QD; He K
Mol Med Rep; 2016 Jan; 13(1):469-76. PubMed ID: 26531171
[TBL] [Abstract][Full Text] [Related]
22. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
[TBL] [Abstract][Full Text] [Related]
23. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
24. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
25. RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells.
Han J; Zhang F; Yu M; Zhao P; Ji W; Zhang H; Wu B; Wang Y; Niu R
Cancer Lett; 2012 Aug; 321(1):80-8. PubMed ID: 22381696
[TBL] [Abstract][Full Text] [Related]
26. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract][Full Text] [Related]
27. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5).
Li D; Liu Y; Li H; Peng JJ; Tan Y; Zou Q; Song XF; Du M; Yang ZH; Tan Y; Zhou JJ; Xu T; Fu ZQ; Feng JQ; Cheng P; chen T; Wei D; Su XM; Liu HY; Qi ZC; Tang LJ; Wang T; Guo X; Hu YH; Zhang T
FEBS Lett; 2015 Jan; 589(1):68-76. PubMed ID: 25433291
[TBL] [Abstract][Full Text] [Related]
29. Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.
Ikeguchi M; Hirooka Y
Pathobiology; 2004; 71(5):281-6. PubMed ID: 15459488
[TBL] [Abstract][Full Text] [Related]
30. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.
Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE
Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of F-LANa, upregulated in human liver cancer.
Ying H; Yu Y; Xu Y
Biochem Biophys Res Commun; 2001 Aug; 286(2):394-400. PubMed ID: 11500051
[TBL] [Abstract][Full Text] [Related]
32. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.
Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
Cell Stem Cell; 2011 Jul; 9(1):50-63. PubMed ID: 21726833
[TBL] [Abstract][Full Text] [Related]
33. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
[TBL] [Abstract][Full Text] [Related]
34. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
[TBL] [Abstract][Full Text] [Related]
35. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
36. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
[TBL] [Abstract][Full Text] [Related]
37. Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays.
Fan R; Huang W; Luo B; Zhang QM; Xiao SW; Xie XX
Eur J Gynaecol Oncol; 2015; 36(3):298-303. PubMed ID: 26189257
[TBL] [Abstract][Full Text] [Related]
38. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
[TBL] [Abstract][Full Text] [Related]
39. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
